Crovalimab
Chugai Pharmaceutical
['commodore ', 'obinu', 'rova,(-approval)', 'rova,(-approval),(-microvascular)', 'imab ']
keeping up with the phase 3 commodore 3 study?novel c5 inhibitor crovalimab shows efficacy and good tolerance in complement inhibitor-naive paroxysmal nocturnal hemoglobinuria w/o new safety signals. #noeticinsight #ash22 